EVERY BI SALES REP (SEVERAL YEARS AGO): “Why isn’t BI developing a Triple Therapy for COPD? Physicians are telling us they are going to prescribe it when it is launched.” BI EXECUTIVE MANAGEMENT: “Physicians are not going to prescribe Triple Therapy very often for COPD! Our data shows that. You will see.” PRESENT FACT: Trelegy Sales surpass Stiolto Sales in less than 6 months. Several other Pharma Companies already developing a Triple Therapy for COPD.